Elixxer Historical Balance Sheet

ELXR Stock

CAD 1.15 0.00 0.00%

Trend analysis of Elixxer balance sheet accounts such as Total Current Liabilities of 8.6 M or Accounts Payable of 1.8 M provides information on Elixxer's total assets, liabilities, and equity, which is the actual value of Elixxer to its prevalent stockholders. By breaking down trends over time using Elixxer balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elixxer. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

About Elixxer Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Elixxer at a specified time, usually calculated after every quarter, six months, or one year. Elixxer Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Elixxer and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Elixxer currently owns. An asset can also be divided into two categories, current and non-current.

Elixxer Balance Sheet Chart

At this time, Elixxer's Total Current Liabilities is fairly stable compared to the past year. Short Term Investments is likely to climb to about 3.6 M in 2024, whereas Other Current Liabilities is likely to drop 3,437 in 2024.

Total Assets Total Current Liabilities Retained Earnings Accounts Payable Net Receivables Common Stock Shares Outstanding

Total Assets

Total assets refers to the total amount of Elixxer assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Elixxer books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Elixxer balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Elixxer are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Accounts Payable

An accounting item on the balance sheet that represents Elixxer obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Elixxer are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Most accounts from Elixxer's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Elixxer current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elixxer. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

	2021	2022	2023	2024 (projected)
Cash	301.8K	65.4K	58.9K	55.9K
Accounts Payable	1.9M	2.9M	3.4M	1.8M

Cash Accounts Payable

Elixxer balance sheet Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Cash	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Net Working Capital	Net Tangible Assets	Non Currrent Assets Other	Other Assets	Other Stockholder Equity	Capital Stock	Common Stock	Property Plant Equipment	Property Plant And Equipment Net	Net Debt	Property Plant And Equipment Gross	Long Term Debt
Total Assets		0.72	0.65	-0.48	0.2	0.35	0.61	0.5	0.2	0.67	0.99	0.8	0.44	-0.48	-0.48	0.1	-0.52	0.24	0.42	0.42	-0.44	-0.05	-0.1	-0.05	0.1
Total Current Liabilities	0.72		-0.04	-0.85	0.66	-0.31	0.48	0.21	0.26	0.96	0.61	0.96	0.2	-0.81	-0.91	-0.3	-0.9	-0.23	0.83	0.83	-0.87	-0.45	-0.45	-0.45	-0.3
Total Stockholder Equity	0.65	-0.04		0.26	-0.52	0.82	0.2	0.49	0.06	-0.13	0.76	0.09	0.46	0.23	0.27	0.47	0.27	0.65	-0.34	-0.33	0.3	0.43	0.35	0.43	0.47
Retained Earnings	-0.48	-0.85	0.26		-0.86	0.51	-0.28	0.3	-0.47	-0.87	-0.34	-0.73	-0.34	0.56	0.94	0.52	0.97	0.48	-0.96	-0.96	0.97	0.83	0.8	0.83	0.52
Accounts Payable	0.2	0.66	-0.52	-0.86		-0.68	0.33	-0.35	0.34	0.8	0.06	0.57	0.07	-0.56	-0.79	-0.4	-0.87	-0.51	0.93	0.93	-0.87	-0.78	-0.71	-0.78	-0.4
Cash	0.35	-0.31	0.82	0.51	-0.68		0.1	0.57	-0.47	-0.35	0.46	-0.18	-0.04	0.22	0.55	0.43	0.57	0.38	-0.61	-0.61	0.6	0.68	0.66	0.68	0.43
Net Receivables	0.61	0.48	0.2	-0.28	0.33	0.1		0.57	-0.13	0.6	0.58	0.7	-0.04	-0.67	-0.17	0.06	-0.41	0.08	0.32	0.31	-0.21	0.11	0.11	0.11	0.06
Common Stock Shares Outstanding	0.5	0.21	0.49	0.3	-0.35	0.57	0.57		-0.58	0.17	0.55	0.4	-0.36	-0.49	0.19	0.47	0.17	0.41	-0.3	-0.3	0.28	0.77	0.76	0.77	0.47
Short Term Investments	0.2	0.26	0.06	-0.47	0.34	-0.47	-0.13	-0.58		0.2	0.17	0.18	0.89	0.28	-0.46	-0.17	-0.47	0.18	0.49	0.5	-0.52	-0.69	-0.78	-0.69	-0.17
Total Liab	0.67	0.96	-0.13	-0.87	0.8	-0.35	0.6	0.17	0.2		0.55	0.94	0.11	-0.85	-0.88	-0.28	-0.93	-0.3	0.88	0.88	-0.87	-0.48	-0.45	-0.48	-0.28
Net Invested Capital	0.99	0.61	0.76	-0.34	0.06	0.46	0.58	0.55	0.17	0.55		0.71	0.45	-0.38	-0.34	0.21	-0.38	0.36	0.28	0.28	-0.31	0.07	0.01	0.07	0.21
Short Long Term Debt	0.8	0.96	0.09	-0.73	0.57	-0.18	0.7	0.4	0.18	0.94	0.71		0.18	-0.85	-0.77	-0.18	-0.83	-0.09	0.73	0.73	-0.74	-0.27	-0.28	-0.27	-0.18
Total Current Assets	0.44	0.2	0.46	-0.34	0.07	-0.04	-0.04	-0.36	0.89	0.11	0.45	0.18		0.36	-0.28	-0.11	-0.31	0.3	0.3	0.3	-0.33	-0.48	-0.59	-0.48	-0.11
Net Working Capital	-0.48	-0.81	0.23	0.56	-0.56	0.22	-0.67	-0.49	0.28	-0.85	-0.38	-0.85	0.36		0.61	0.19	0.66	0.33	-0.58	-0.57	0.57	0.08	0.02	0.08	0.19
Net Tangible Assets	-0.48	-0.91	0.27	0.94	-0.79	0.55	-0.17	0.19	-0.46	-0.88	-0.34	-0.77	-0.28	0.61		0.44	0.95	0.39	-0.93	-0.93	0.98	0.73	0.71	0.73	0.44
Non Currrent Assets Other	0.1	-0.3	0.47	0.52	-0.4	0.43	0.06	0.47	-0.17	-0.28	0.21	-0.18	-0.11	0.19	0.44		0.47	0.86	-0.5	-0.49	0.46	0.61	0.63	0.61	1.0
Other Assets	-0.52	-0.9	0.27	0.97	-0.87	0.57	-0.41	0.17	-0.47	-0.93	-0.38	-0.83	-0.31	0.66	0.95	0.47		0.39	-0.97	-0.97	0.97	0.75	0.74	0.75	0.47
Other Stockholder Equity	0.24	-0.23	0.65	0.48	-0.51	0.38	0.08	0.41	0.18	-0.3	0.36	-0.09	0.3	0.33	0.39	0.86	0.39		-0.47	-0.45	0.41	0.52	0.45	0.52	0.86
Capital Stock	0.42	0.83	-0.34	-0.96	0.93	-0.61	0.32	-0.3	0.49	0.88	0.28	0.73	0.3	-0.58	-0.93	-0.5	-0.97	-0.47		1.0	-0.98	-0.82	-0.8	-0.82	-0.5
Common Stock	0.42	0.83	-0.33	-0.96	0.93	-0.61	0.31	-0.3	0.5	0.88	0.28	0.73	0.3	-0.57	-0.93	-0.49	-0.97	-0.45	1.0		-0.98	-0.82	-0.8	-0.82	-0.49
Property Plant Equipment	-0.44	-0.87	0.3	0.97	-0.87	0.6	-0.21	0.28	-0.52	-0.87	-0.31	-0.74	-0.33	0.57	0.98	0.46	0.97	0.41	-0.98	-0.98		0.81	0.79	0.81	0.46
Property Plant And Equipment Net	-0.05	-0.45	0.43	0.83	-0.78	0.68	0.11	0.77	-0.69	-0.48	0.07	-0.27	-0.48	0.08	0.73	0.61	0.75	0.52	-0.82	-0.82	0.81		0.98	1.0	0.61
Net Debt	-0.1	-0.45	0.35	0.8	-0.71	0.66	0.11	0.76	-0.78	-0.45	0.01	-0.28	-0.59	0.02	0.71	0.63	0.74	0.45	-0.8	-0.8	0.79	0.98		0.98	0.63
Property Plant And Equipment Gross	-0.05	-0.45	0.43	0.83	-0.78	0.68	0.11	0.77	-0.69	-0.48	0.07	-0.27	-0.48	0.08	0.73	0.61	0.75	0.52	-0.82	-0.82	0.81	1.0	0.98		0.61
Long Term Debt	0.1	-0.3	0.47	0.52	-0.4	0.43	0.06	0.47	-0.17	-0.28	0.21	-0.18	-0.11	0.19	0.44	1.0	0.47	0.86	-0.5	-0.49	0.46	0.61	0.63	0.61

Click cells to compare fundamentals

Elixxer Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Elixxer Stock Analysis

When running Elixxer's price analysis, check to measure Elixxer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixxer is operating at the current time. Most of Elixxer's value examination focuses on studying past and present price action to predict the probability of Elixxer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixxer's price. Additionally, you may evaluate how the addition of Elixxer to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC